Get Live Data

focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share News
  5. BROKER RATINGS SUMMARY: Investec Starts Wolseley With Hold Rating

Pin to quick picksGlaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,785.50
Bid: 1,785.00
Ask: 1,785.50
Change: -27.00 (-1.49%)
Spread: 0.50 (0.028%)
Open: 1,792.50
High: 1,802.00
Low: 1,782.00
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Investec Starts Wolseley With Hold Rating

Wed, 12th Oct 2016 08:27

LONDON (Alliance News) - The following shares received analyst recommendations Wednesday morning and Tuesday:
----------
FTSE 100
----------
TRADERS: INVESTEC INITIATES WOLSELEY WITH 'HOLD'
----------
DEUTSCHE BANK RAISES SHIRE PRICE TARGET TO 6200 (6000) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES GLAXOSMITHKLINE PRICE TARGET TO 1870 (1800) PENCE - 'HOLD'
----------
DEUTSCHE BANK RAISES ASTRAZENECA PRICE TARGET TO 6200 (5800) PENCE - 'BUY'
----------
TRADERS: MERRILL LYNCH REMOVES BT GROUP FROM 'EUROPE 1 LIST'
----------
GOLDMAN RAISES VODAFONE PRICE TARGET TO 275 (265) PENCE - 'NEUTRAL'
----------
UBS RAISES BURBERRY PRICE TARGET TO 1800 (1650) PENCE - 'BUY'
----------
FTSE 250
----------
HSBC RAISES PAGEGROUP PRICE TARGET TO 385 (320) PENCE - 'HOLD'
----------
BARCLAYS RAISES PAGEGROUP PRICE TARGET TO 390 (340) PENCE - 'EQUAL WEIGHT'
----------
GOLDMAN RAISES PAGEGROUP PRICE TARGET TO 347 (333) PENCE - 'SELL'
----------
TRADERS: KEPLER CHEUVREUX RAISES PAGEGROUP TO 'HOLD' ('REDUCE')
----------
LIBERUM RAISES ASHMORE GROUP TO 'HOLD' ('SELL') - PRICE TARGET 379 (240) PENCE
----------
DEUTSCHE BANK RAISES ZOOPLA PROPERTY PRICE TARGET TO 300 (280) PENCE - 'HOLD'
----------
Investec Lifts OneSavings Bank Target To 360p From 355p, Keeps At Buy
----------
Cantor Fitzgerald Cuts Sports Direct Target To 260p From 320p, Hold
----------
BERENBERG RAISES VICTREX PRICE TARGET TO 1650 (1510) PENCE - 'HOLD'
----------
CITIGROUP RAISES ELECTROCOMPONENTS TO 'NEUTRAL' ('SELL') - PRICE TARGET 375 PENCE
----------
MAIN MARKET AND AIM
----------
DAVY CUTS PREMIER FOODS TO 'NEUTRAL' ('OUTPERFORM')
----------
PANMURE RAISES ANIMALCARE GROUP PRICE TARGET TO 370 (337) PENCE - 'BUY'
----------
N+1 Lifts Walker Greenbank To Buy From Hold, Target 250p From 200p
----------
LIBERUM CUTS MELROSE INDUSTRIES TO 'HOLD' ('BUY') - PRICE TARGET 200 PENCE
----------
GOLDMAN RAISES SECURE INCOME PRICE TARGET TO 370 (308) PENCE - 'NEUTRAL'
----------

PANMURE CUTS VERNALIS PLC PRICE TARGET TO 65 (76) PENCE - 'BUY'

---------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:45

Citi ups recommendation on GSK to 'buy'

(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
13 Feb 2024 07:45

LONDON BRIEFING: "Record" Tui quarter; Ultimate Products eyes payouts

(Alliance News) - London's FTSE 100 is to open ever-so-slightly lower on Tuesday, with trade set to be nervy ahead of the afternoon's US inflation data.

Read more
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
12345678910

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.